| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8735259 | Hepatobiliary & Pancreatic Diseases International | 2018 | 5 Pages |
Abstract
Octreotide did not reduce postoperative morbidities, reoperation and mortality rate. Also, it did not affect the incidence of POPF and its clinically relevant variants.
Related Topics
Health Sciences
Medicine and Dentistry
Hepatology
Authors
Ayman El Nakeeb, Ahmed ElGawalby, Mahmoud A. Ali, Ahmed Shehta, Hosam Hamed, Mohamed El Refea, Ahmed Moneer, Ahmed Abd El Rafee,